PL369261A1 - Zastosowanie (11beta, 17beta)-11-(1,3-benzodioksol-5-ilo)-17-hydroksy-17-(1-propynylo)-estra-4,9-dien-3-onu do leczenia uogólnionych zaburzeń depresyjnych - Google Patents

Zastosowanie (11beta, 17beta)-11-(1,3-benzodioksol-5-ilo)-17-hydroksy-17-(1-propynylo)-estra-4,9-dien-3-onu do leczenia uogólnionych zaburzeń depresyjnych

Info

Publication number: PL369261A1
Authority: PL; Poland
Prior art keywords: estra; benzodioxol; dien; propynyl; hydroxy
Prior art date: 2001-10-26

Application number

PL02369261A

Other languages

English (en)

Other versions

PL206687B1 (pl

Inventor

Cornelis Sennef

Bernardus Wijnand Mathys Marie Peeters

Original Assignee

Akzo Nobel N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-26

Filing date

2002-10-21

Publication date

2005-04-18

2002-10-21 Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.

2005-04-18 Publication of PL369261A1 publication Critical patent/PL369261A1/pl

2010-09-30 Publication of PL206687B1 publication Critical patent/PL206687B1/pl

Links

208000024714 major depressive disease Diseases 0.000 title 1
DFELGYQKEOCHOA-BZAFBGKRSA-N (8s,11r,13s,14s,17s)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=C2OCOC2=CC([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=C1 DFELGYQKEOCHOA-BZAFBGKRSA-N 0.000 abstract 2
DBLOJPKZEOYNBN-SQNIBIBYSA-N (8s,13s,14s)-13-methyl-2,6,7,8,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 DBLOJPKZEOYNBN-SQNIBIBYSA-N 0.000 abstract 1
208000020401 Depressive disease Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940126013 glucocorticoid receptor antagonist Drugs 0.000 abstract 1
239000003850 glucocorticoid receptor antagonist Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL369261A 2001-10-26 2002-10-21 Zastosowanie (11ß, 17ß)-11-(1,3-benzodioksol-5-ilo)-17-hydroksy-17-(1-propynylo)-estra-4,9-dien-3-onu do wytwarzania leku do leczenia uogólnionych zaburzeń depresyjnych PL206687B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01204072		2001-10-26

Publications (2)

Publication Number	Publication Date
PL369261A1 true PL369261A1 (pl)	2005-04-18
PL206687B1 PL206687B1 (pl)	2010-09-30

Family

ID=8181136

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL369261A PL206687B1 (pl)	2001-10-26	2002-10-21	Zastosowanie (11ß, 17ß)-11-(1,3-benzodioksol-5-ilo)-17-hydroksy-17-(1-propynylo)-estra-4,9-dien-3-onu do wytwarzania leku do leczenia uogólnionych zaburzeń depresyjnych

Country Status (26)

Country	Link
US (1)	US20040266863A1 (pl)
EP (2)	EP1652526B1 (pl)
JP (1)	JP4647909B2 (pl)
KR (1)	KR20050038580A (pl)
CN (1)	CN100531738C (pl)
AT (2)	ATE420649T1 (pl)
AU (1)	AU2002348996B2 (pl)
BR (1)	BR0213466A (pl)
CA (1)	CA2463446C (pl)
CY (1)	CY1110173T1 (pl)
DE (2)	DE60209248D1 (pl)
DK (1)	DK1652526T3 (pl)
EC (1)	ECSP045080A (pl)
ES (1)	ES2319563T3 (pl)
HR (1)	HRP20040370B1 (pl)
HU (1)	HUP0500070A3 (pl)
IL (2)	IL161248A0 (pl)
IS (1)	IS2702B (pl)
MX (1)	MXPA04003781A (pl)
NO (1)	NO332978B1 (pl)
NZ (1)	NZ532429A (pl)
PL (1)	PL206687B1 (pl)
PT (1)	PT1652526E (pl)
RU (1)	RU2302245C2 (pl)
WO (1)	WO2003037354A1 (pl)
ZA (1)	ZA200403088B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050080061A1 (en) *	2003-07-23	2005-04-14	Corcept Therapeutics, Inc.	Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
AU2011236053B2 (en) *	2004-11-19	2014-06-26	Merck Sharpe & Dohme B.V.	Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
CA2585317C (en) *	2004-11-19	2015-02-24	N.V. Organon	Drug combination for the treatment of depression and related disorders comprising a selective serotonin reuptake inhibitor
JP2009535430A (ja) *	2006-05-02	2009-10-01	コーセプトセラピューティクス，インコーポレイテッド	Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
US8658128B2 (en) *	2011-02-03	2014-02-25	Pop Test Cortisol Llc	System and method for diagnosis and treatment
WO2012145258A1 (en) *	2011-04-18	2012-10-26	Pop Test Cortisol Llc	Hair loss treatment
US8986677B2 (en) *	2012-07-30	2015-03-24	Pop Test Cortisol Llc	Therapeutic compositions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4814333A (en) *	1987-07-28	1989-03-21	The Trustees Of Dartmouth College	Method for treatment of hypercortisolemic, depressed patients
DE4447401A1 (de) *	1994-12-23	1996-07-04	Schering Ag	14,17-C¶2¶-überbrückte Steroide
IL118974A (en) *	1995-08-17	2001-09-13	Akzo Nobel Nv	History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) *	1997-06-30	1999-01-28	Forschungszentrum Juelich Gmbh	Magnetflußsensor mit ringförmiger Sonde
AU747956B2 (en) *	1997-10-06	2002-05-30	Board Of Trustees Of The Leland Stanford Junior University	Methods for treating psychosis associated with glucocorticoid related dysfunction
JP2004525135A (ja) *	2001-03-23	2004-08-19	コーセプトセラピューティクス，インコーポレイテッド	糖質コルチコイドレセプター特異的アンタゴニストを使用するストレス障害を処置するための方法
ATE492281T1 (de) *	2001-05-04	2011-01-15	Corcept Therapeutics Inc	Verwendung von glucocorticoid-rezeptor- spezifischen antagonisten zur behandlung von delirium
ATE411013T1 (de) *	2001-08-31	2008-10-15	Corcept Therapeutics Inc	Verfahren zur hemmung der verschlechterung der kognitiven leistungsfähigkeit bei erwachsenen mit down-syndrom

2002
- 2002-10-21 CN CNB028210417A patent/CN100531738C/zh not_active Expired - Fee Related
- 2002-10-21 PT PT06101005T patent/PT1652526E/pt unknown
- 2002-10-21 WO PCT/EP2002/011732 patent/WO2003037354A1/en not_active Ceased
- 2002-10-21 NZ NZ532429A patent/NZ532429A/en not_active IP Right Cessation
- 2002-10-21 BR BR0213466-7A patent/BR0213466A/pt not_active IP Right Cessation
- 2002-10-21 DE DE60209248T patent/DE60209248D1/de not_active Expired - Lifetime
- 2002-10-21 KR KR1020047006050A patent/KR20050038580A/ko not_active Ceased
- 2002-10-21 PL PL369261A patent/PL206687B1/pl not_active IP Right Cessation
- 2002-10-21 US US10/493,981 patent/US20040266863A1/en not_active Abandoned
- 2002-10-21 HU HU0500070A patent/HUP0500070A3/hu unknown
- 2002-10-21 ES ES06101005T patent/ES2319563T3/es not_active Expired - Lifetime
- 2002-10-21 EP EP06101005A patent/EP1652526B1/en not_active Expired - Lifetime
- 2002-10-21 DK DK06101005T patent/DK1652526T3/da active
- 2002-10-21 EP EP02781273A patent/EP1441739B1/en not_active Expired - Lifetime
- 2002-10-21 JP JP2003539697A patent/JP4647909B2/ja not_active Expired - Fee Related
- 2002-10-21 AU AU2002348996A patent/AU2002348996B2/en not_active Ceased
- 2002-10-21 HR HRP20040370AA patent/HRP20040370B1/xx not_active IP Right Cessation
- 2002-10-21 AT AT06101005T patent/ATE420649T1/de active
- 2002-10-21 MX MXPA04003781A patent/MXPA04003781A/es active IP Right Grant
- 2002-10-21 AT AT02781273T patent/ATE317700T1/de active
- 2002-10-21 RU RU2004116082/15A patent/RU2302245C2/ru not_active IP Right Cessation
- 2002-10-21 IL IL16124802A patent/IL161248A0/xx unknown
- 2002-10-21 DE DE60230936T patent/DE60230936D1/de not_active Expired - Lifetime
- 2002-10-21 CA CA2463446A patent/CA2463446C/en not_active Expired - Fee Related
2004
- 2004-03-31 IS IS7204A patent/IS2702B/is unknown
- 2004-04-01 IL IL161248A patent/IL161248A/en not_active IP Right Cessation
- 2004-04-22 ZA ZA200403088A patent/ZA200403088B/en unknown
- 2004-04-23 NO NO20041651A patent/NO332978B1/no not_active IP Right Cessation
- 2004-04-23 EC EC2004005080A patent/ECSP045080A/es unknown
2009
- 2009-02-02 CY CY20091100116T patent/CY1110173T1/el unknown

Also Published As

Publication number	Publication date
ZA200403088B (en)	2005-01-24
HUP0500070A2 (hu)	2005-04-28
RU2004116082A (ru)	2005-05-10
IL161248A (en)	2010-12-30
EP1652526A2 (en)	2006-05-03
EP1441739B1 (en)	2006-02-15
DE60209248D1 (de)	2006-04-20
IL161248A0 (en)	2004-09-27
AU2002348996B2 (en)	2008-06-05
IS7204A (is)	2004-03-31
ECSP045080A (es)	2004-06-28
WO2003037354A1 (en)	2003-05-08
DK1652526T3 (da)	2009-05-18
KR20050038580A (ko)	2005-04-27
HRP20040370B1 (hr)	2012-09-30
JP4647909B2 (ja)	2011-03-09
NZ532429A (en)	2004-10-29
MXPA04003781A (es)	2004-07-30
CN1582153A (zh)	2005-02-16
HK1087357A1 (en)	2006-10-13
ATE420649T1 (de)	2009-01-15
ES2319563T3 (es)	2009-05-08
DE60230936D1 (de)	2009-03-05
EP1652526A3 (en)	2006-08-02
PL206687B1 (pl)	2010-09-30
EP1652526B1 (en)	2009-01-14
HRP20040370A2 (en)	2004-08-31
US20040266863A1 (en)	2004-12-30
HUP0500070A3 (en)	2012-09-28
JP2005521637A (ja)	2005-07-21
NO20041651L (no)	2004-04-23
RU2302245C2 (ru)	2007-07-10
CY1110173T1 (el)	2015-01-14
EP1441739A1 (en)	2004-08-04
CA2463446A1 (en)	2003-05-08
CA2463446C (en)	2010-02-23
ATE317700T1 (de)	2006-03-15
PT1652526E (pt)	2009-02-06
NO332978B1 (no)	2013-02-11
CN100531738C (zh)	2009-08-26
IS2702B (is)	2010-11-15
BR0213466A (pt)	2004-11-09

Similar Documents

Publication	Publication Date	Title
ZA200405657B (en)	2005-08-29	Formulation & dosage form for the controlled delivery of therapeutic agents.
UA83620C2 (ru)	2008-08-11	Замещенные бензоксазолы и их аналоги как эстрогенные агенты
ES2124905T3 (es)	1999-02-16	Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
MXPA04005784A (es)	2004-09-13	2-fenilbenzofuranos sustituidos como agentes estrogenitos.
SG153645A1 (en)	2009-07-29	Hormone replacement therapy
HRP20030387A2 (en)	2005-04-30	Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
CY1110173T1 (el)	2015-01-14	Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης
IL159714A (en)	2010-12-30	Pharmaceutical composition for oral delivery comprising a fragment of parathyroid hormone and 5-cnac
HUP0402028A3 (en)	2008-03-28	Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
IL133632A (en)	2003-10-31	Use of a specific 5ht2 receptor antagonist for the preparation of pharmaceutical compositions useful in the treatment of the sleep apnea syndrome
MXPA01008993A (es)	2004-11-10	Tratamiento de combinacion para depresion y ansiedad.
BR0207066A (pt)	2004-03-30	Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
EA200501739A1 (ru)	2006-06-30	Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний
WO2002074315A8 (de)	2004-06-03	Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
ATE419855T1 (de)	2009-01-15	Therapie für hormonersatz und depression enthaltend dienogest
HUP0202347A2 (en)	2002-10-28	N-acylated pseudomycin analogs, process for their preparation, pharmaceutical compositions comprising thereof and their use
HK1068097A (en)	2005-04-22	Use of (11beta, 17beta)-11- (1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4, 9-dien-3-one in the treatment of major depressive disorder
IL157272A0 (en)	2004-02-19	Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
PE20020520A1 (es)	2002-06-15	Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
IL125983A0 (en)	1999-04-11	Pharmaceutical composition comprising factor xiiia
BR0304292A (pt)	2005-06-28	Preparado de combinação de estrogênio-gestagênio e uso

Legal Events

Date	Code	Title	Description
2014-11-28	LAPS	Decisions on the lapse of the protection rights	Effective date: 20131021